8-K Announcements
6Apr 7, 2026·SEC
Mar 18, 2026·SEC
Feb 27, 2026·SEC
American Healthcare REIT, Inc. (AHR) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
American Healthcare REIT, Inc. (AHR) stock price & volume — 10-year historical chart
American Healthcare REIT, Inc. (AHR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
American Healthcare REIT, Inc. (AHR) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 26, 2026 | $0.06vs $0.15-61.3% | $604Mvs $609M-0.9% |
| Q4 2025 | Nov 6, 2025 | $0.33vs $0.42-21.4% | $573Mvs $615M-6.9% |
| Q3 2025 | Aug 7, 2025 | $0.06vs $0.40-85.0% | $543Mvs $553M-1.9% |
| Q2 2025 | May 8, 2025 | $0.04vs $0.37-110.8% | $541Mvs $541M-0.1% |
American Healthcare REIT, Inc. (AHR) competitors in Diversified healthcare real estate — business model, growth, and fundamentals comparison
American Healthcare REIT, Inc. (AHR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
American Healthcare REIT, Inc. (AHR) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 980.29M | 1.05B | 1.13B | 1.22B | 1.18B | 1.26B | 1.62B | 1.86B | 2.07B | 2.2B |
| Revenue Growth % | - | 7.03% | 7.83% | 7.92% | -2.98% | 6.7% | 27.97% | 14.94% | 11.38% | 9.37% |
| Property Operating Expenses | 800.1M | 837.64M | 923.82M | 1B | 1.03B | 1.08B | 1.28B | 1.5B | 1.65B | 1.74B |
| Net Operating Income (NOI) | 180.19M▲ 0% | 211.6M▲ 17.4% | 207.56M▼ 1.9% | 219.3M▲ 5.7% | 158.58M▼ 27.7% | 182.01M▲ 14.8% | 335.97M▲ 84.6% | 356.83M▲ 6.2% | 416.77M▲ 16.8% | 454.97M▲ 0% |
| NOI Margin % | 18.38% | 20.17% | 18.35% | 17.96% | 13.39% | 14.4% | 20.77% | 19.19% | 20.13% | 20.69% |
| Operating Expenses | 28.68M | 32.17M | 28.42M | 29.75M | 27.01M | 43.2M | 245.38M | 280.11M | 279.99M | 285.74M |
| G&A Expenses | 28.68M | 32.17M | 28.42M | 29.75M | 27.01M | 43.2M | 103.1M | 104.98M | 100.8M | 93.94M |
| EBITDA | 423.73M | 293.05M | 275.41M | 329.68M | 264M | 292.62M | 291.19M | 314.01M | 358.42M | 377.75M |
| EBITDA Margin % | 43.22% | 27.93% | 24.34% | 27% | 22.29% | 23.15% | 18% | 16.89% | 17.31% | 17.18% |
| Depreciation & Amortization | 272.21M | 113.63M | 96.27M | 140.12M | 132.43M | 153.81M | 200.6M | 237.3M | 221.64M | 208.51M |
| D&A / Revenue % | 27.77% | 10.83% | 8.51% | 11.48% | 11.18% | 12.17% | 12.4% | 12.76% | 10.7% | 9.48% |
| Operating Income | 151.51M▲ 0% | 179.43M▲ 18.4% | 179.14M▼ 0.2% | 189.55M▲ 5.8% | 131.57M▼ 30.6% | 138.81M▲ 5.5% | 90.59M▼ 34.7% | 76.72M▼ 15.3% | 136.78M▲ 78.3% | 169.24M▲ 0% |
| Operating Margin % | 15.46% | 17.1% | 15.83% | 15.52% | 11.11% | 10.98% | 5.6% | 4.13% | 6.61% | 7.7% |
| Interest Expense | 45.66M | 60.87M | 66.28M | 78.55M | 71.28M | 80.94M | 105.96M | 163.19M | 127.73M | 3M |
| Interest Coverage | 3.32x | 2.95x | 2.70x | 2.41x | 1.85x | 1.72x | 0.85x | 0.47x | 1.07x | - |
| Non-Operating Income | 271.58M | 113.64M | 96.03M | 111.41M | 98.86M | 133.19M | 57.43M | -10.25M | 42.94M | 85.18M |
| Pretax Income | -203.55M▲ 0% | 2.12M▲ 101.0% | 13.74M▲ 547.2% | -860K▼ 106.3% | 5.79M▲ 772.7% | -52.31M▼ 1004.3% | -72.8M▼ 39.2% | -76.22M▼ 4.7% | -33.89M▲ 55.5% | 8.18M▲ 0% |
| Pretax Margin % | -20.76% | 0.2% | 1.21% | -0.07% | 0.49% | -4.14% | -4.5% | -4.1% | -1.64% | 0.37% |
| Income Tax | 0 | 0 | 8K | -8K | -3.08M | 956K | 586K | 663K | 1.71M | -19.27M |
| Effective Tax Rate % | 0% | 0% | 0.06% | 0.93% | -53.21% | -1.83% | -0.8% | -0.87% | -5.06% | -235.6% |
| Net Income | -146.03M▲ 0% | 11.22M▲ 107.7% | 13.3M▲ 18.5% | -4.96M▼ 137.3% | 2.16M▲ 143.6% | -47.79M▼ 2309.6% | -81.3M▼ 70.1% | -71.47M▲ 12.1% | -37.81M▲ 47.1% | 27.26M▲ 0% |
| Net Margin % | -14.9% | 1.07% | 1.18% | -0.41% | 0.18% | -3.78% | -5.03% | -3.84% | -1.83% | 1.24% |
| Net Income Growth % | - | 107.68% | 18.49% | -137.34% | 143.56% | -2309.62% | -70.11% | 12.09% | 47.09% | 181.45% |
| Funds From Operations (FFO) | 126.18M▲ 0% | 124.85M▼ 1.1% | 109.57M▼ 12.2% | 135.16M▲ 23.4% | 134.59M▼ 0.4% | 106.01M▼ 21.2% | 119.3M▲ 12.5% | 165.83M▲ 39.0% | 183.82M▲ 10.9% | 235.77M▲ 0% |
| FFO Margin % | 12.87% | 11.9% | 9.68% | 11.07% | 11.36% | 8.39% | 7.38% | 8.92% | 8.88% | 10.72% |
| FFO Growth % | - | -1.06% | -12.24% | 23.36% | -0.42% | -21.23% | 12.53% | 39% | 10.85% | 106.27% |
| FFO per Share | 2.60 | 2.52 | 2.19 | 2.97 | 2.04 | 1.60 | 1.80 | 2.51 | 1.41 | 1.45 |
| FFO Payout Ratio % | 40.96% | 44.68% | 54.74% | 46.32% | 20.06% | 21.5% | 42.85% | 46% | 65.77% | 83.62% |
| EPS (Diluted) | -3.01▲ 0% | 0.23▲ 107.6% | 0.27▲ 17.4% | -0.11▼ 140.7% | 0.03▲ 129.7% | -0.72▼ 2301.8% | -1.23▼ 70.8% | -1.08▲ 12.2% | -0.29▲ 73.1% | 0.17▲ 0% |
| EPS Growth % | - | 107.64% | 17.39% | -140.74% | 129.73% | -2301.83% | -70.83% | 12.2% | 73.15% | 129.19% |
| EPS (Basic) | -3.01 | 0.23 | 0.27 | -0.11 | 0.03 | -0.72 | -1.23 | -1.08 | -0.29 | - |
| Diluted Shares Outstanding | 48.55M | 49.56M | 49.99M | 45.48M | 66.05M | 66.21M | 66.21M | 66.05M | 130.64M | 162.91M |
American Healthcare REIT, Inc. (AHR) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 2.79B | 2.8B | 2.89B | 3.17B | 3.23B | 4.58B | 4.79B | 4.58B | 4.49B | 4.77B |
| Asset Growth % | - | 0.21% | 3.16% | 9.8% | 1.97% | 41.59% | 4.51% | -4.36% | -1.96% | -8.03% |
| Real Estate & Other Assets | 26.66M | 23.2M | 24.51M | 22.79M | 21.68M | 23.06M | 26.36M | 3.53B | 3.47B | 3.7B |
| PP&E (Net) | 2.14B | 2.16B | 2.22B | 2.49B | 2.53B | 3.67B | 3.86B | 227.85M | 163.99M | 140.7M |
| Investment Securities | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Total Current Assets | 269.55M | 275.51M | 303.29M | 331.44M | 356.95M | 330.74M | 341.92M | 297.1M | 354.89M | 393.38M |
| Cash & Equivalents | 29.12M | 33.66M | 35.13M | 53.15M | 113.21M | 81.6M | 65.05M | 43.45M | 76.7M | 147.36M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 83.67M | 87.89M | 100.75M | 77.08M | 55.6M | 66.37M | 72.72M | 48.8M | 47.61M | 37.17M |
| Intangible Assets | 200.83M | 180.31M | 179.52M | 160.25M | 154.69M | 248.87M | 236.28M | 180.47M | 161.47M | 181.37M |
| Total Liabilities | 1.34B | 1.42B | 1.63B | 2.07B | 2.16B | 2.75B | 3.14B | 3.12B | 2.18B | 2.05B |
| Total Debt | 1.19B | 1.25B | 1.45B | 1.85B | 1.88B | 2.5B | 2.83B | 3.02B | 1.87B | 1.7B |
| Net Debt | 1.16B | 1.22B | 1.42B | 1.79B | 1.76B | 2.42B | 2.77B | 2.98B | 1.79B | 1.55B |
| Long-Term Debt | 1.15B | 1.24B | 1.45B | 1.64B | 1.68B | 1.43B | 2.24B | 1.34B | 1.02B | 1.01B |
| Short-Term Borrowings | 0 | 0 | 0 | 0 | 0 | 921.9M | 316.73M | 1.22B | 688.53M | 549.7M |
| Capital Lease Obligations | 45.3M | 16.19M | 4.7M | 207.37M | 193.63M | 145.49M | 273.07M | 451M | 165.24M | 608.32M |
| Total Current Liabilities | 107.33M | 126.56M | 144.79M | 173.72M | 194.68M | 1.11B | 560.57M | 1.47B | 946.86M | 847.75M |
| Accounts Payable | 37.18M | 43.97M | 43.03M | 62.2M | 67.83M | 64.41M | 83.69M | 242.91M | 258.32M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 46.8M | 41.03M | 38.47M | 48.77M | 89.27M | 60.78M | 60.38M | 82.23M | 54.86M | 55.8M |
| Total Equity | 1.45B▲ 0% | 1.38B▼ 4.9% | 1.26B▼ 8.9% | 1.1B▼ 12.3% | 1.07B▼ 2.5% | 1.83B▲ 70.2% | 1.65B▼ 9.8% | 1.46B▼ 11.5% | 2.3B▲ 57.9% | 2.72B▲ 0% |
| Equity Growth % | - | -4.9% | -8.86% | -12.26% | -2.53% | 70.22% | -9.85% | -11.53% | 57.91% | 103% |
| Shareholders Equity | 1.26B | 1.19B | 1.06B | 900.55M | 866.11M | 1.58B | 1.4B | 1.27B | 2.26B | 2.68B |
| Minority Interest | 187.27M | 191.16M | 196.37M | 202.21M | 208.72M | 248.28M | 249.27M | 188.86M | 42.93M | 41.75M |
| Common Stock | 1.96M | 1.99M | 1.98M | 1.94M | 1.8M | 658K | 661K | 661K | 1.56M | 1.7M |
| Additional Paid-in Capital | 1.75B | 1.79B | 1.77B | 1.73B | 1.73B | 2.53B | 2.54B | 2.55B | 3.72B | 4.2B |
| Retained Earnings | -490.3M | -598.04M | -704.75M | -827.55M | -864.27M | -951.3M | -1.14B | -1.28B | -1.46B | -1.52B |
| Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on Assets (ROA) | -5.23% | 0.4% | 0.47% | -0.16% | 0.07% | -1.22% | -1.74% | -1.53% | -0.83% | 0.57% |
| Return on Equity (ROE) | -10.07% | 0.79% | 1.01% | -0.42% | 0.2% | -3.29% | -4.67% | -4.6% | -2.01% | 1% |
| Debt / Assets | 42.6% | 44.77% | 50.27% | 58.22% | 58% | 54.62% | 59.19% | 65.95% | 41.68% | 35.56% |
| Debt / Equity | 0.82x | 0.91x | 1.16x | 1.67x | 1.75x | 1.37x | 1.72x | 2.07x | 0.81x | 0.81x |
| Net Debt / EBITDA | 2.74x | 4.16x | 5.15x | 5.44x | 6.68x | 8.27x | 9.51x | 9.48x | 5.01x | 5.01x |
| Book Value per Share | 29.87 | 27.83 | 25.14 | 24.25 | 16.27 | 27.63 | 24.91 | 22.09 | 17.64 | 16.70 |
American Healthcare REIT, Inc. (AHR) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 114.36M | 128.1M | 106.81M | 117.45M | 219.16M | 17.91M | 147.77M | 98.53M | 176.09M | 176.09M |
| Operating CF Growth % | - | 12.02% | -16.62% | 9.96% | 86.59% | -91.83% | 724.92% | -33.32% | 78.7% | 1339.11% |
| Operating CF / Revenue % | 11.67% | 12.21% | 9.44% | 9.62% | 18.5% | 1.42% | 9.14% | 5.3% | 8.5% | 8.01% |
| Net Income | -146.03M | 11.22M | 13.3M | -4.96M | 2.16M | -53.27M | -73.38M | -76.89M | -35.6M | 27.26M |
| Depreciation & Amortization | 277.67M | 121.42M | 103.31M | 144.14M | 132.95M | 157.38M | 200.6M | 237.3M | 221.64M | 189.3M |
| Stock-Based Compensation | 1.82M | 1.2M | 3.24M | 2.96M | -1.19M | 9.66M | 3.91M | 5.47M | 9.87M | 11.21M |
| Other Non-Cash Items | -2M | 16.82M | 8.08M | 24.24M | 10.97M | -2.39M | 54.44M | -11.55M | 48.86M | 107.48M |
| Working Capital Changes | -17.09M | -22.57M | -21.12M | -48.92M | 74.19M | -93.47M | -37.8M | -55.79M | -68.68M | -15.24M |
| Cash from Investing | -352.69M | -124.55M | -135.77M | -103.11M | -147.94M | -138.65M | -118.58M | 9.4M | -8.73M | -286.11M |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 | -650K | -18.57M | -12.93M | -235K | -235K |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K |
| Other Investing | -306.7M | -81M | -68.86M | -10.28M | -19.64M | -58.31M | -28.49M | 122.11M | 83.44M | -302.77M |
| Cash from Financing | 226.66M | 4.76M | 37.6M | 2.69M | -8.81M | 94.11M | -42.92M | -129.06M | -134.74M | 55.06M |
| Dividends Paid | -51.68M | -55.78M | -59.97M | -62.61M | -27M | -22.79M | -51.12M | -76.28M | -120.89M | -197.15M |
| Common Dividends | -51.68M | -55.78M | -59.97M | -62.61M | -27M | -22.79M | -51.12M | -76.28M | -120.89M | -197.15M |
| Debt Issuance (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | -1000K | -4M |
| Share Repurchases | -20.94M | -30.66M | -76.58M | -89.89M | -23.11M | -382K | -20.7M | -469K | -14K | 0 |
| Other Financing | 9.77M | 1.71M | -8.42M | -17.98M | -724K | -29.04M | -33.93M | -34.72M | -382.64M | 263.48M |
| Net Change in Cash | -11.81M▲ 0% | 8.47M▲ 171.7% | 8.56M▲ 1.1% | 17.18M▲ 100.6% | 62.31M▲ 262.8% | -26.7M▼ 142.9% | -13.58M▲ 49.1% | -21.12M▼ 55.6% | 32.52M▲ 253.9% | 67.69M▲ 0% |
| Exchange Rate Effect | -140K | 149K | -77K | 145K | -90K | -74K | 154K | 7K | -91K | -105K |
| Cash at Beginning | 67.49M | 55.68M | 64.14M | 72.7M | 89.88M | 152.19M | 125.49M | 111.91M | 90.78M | 169.99M |
| Cash at End | 55.68M | 64.14M | 72.7M | 89.88M | 152.19M | 125.49M | 111.91M | 90.78M | 123.3M | 184.36M |
| Free Cash Flow | 68.37M▲ 0% | 84.55M▲ 23.7% | 39.91M▼ 52.8% | 24.62M▼ 38.3% | 90.85M▲ 269.1% | -61.78M▼ 168.0% | 76.25M▲ 223.4% | -1.26M▼ 101.6% | 84.15M▲ 6799.6% | 269.1M▲ 0% |
| FCF Growth % | - | 23.66% | -52.8% | -38.31% | 269.06% | -168% | 223.41% | -101.65% | 6799.6% | 392.08% |
| FCF / Revenue % | 6.97% | 8.06% | 3.53% | 2.02% | 7.67% | -4.89% | 4.71% | -0.07% | 4.06% | 12.24% |
American Healthcare REIT, Inc. (AHR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| FFO per Share | 2.52 | 2.19 | 2.97 | 2.04 | 1.6 | 1.8 | 2.51 | 1.41 | 1.45 |
| FFO Payout Ratio | 44.68% | 54.74% | 46.32% | 20.06% | 21.5% | 42.85% | 46% | 65.77% | 83.62% |
| NOI Margin | 20.17% | 18.35% | 17.96% | 13.39% | 14.4% | 20.77% | 19.19% | 20.13% | 20.69% |
| Net Debt / EBITDA | 4.16x | 5.15x | 5.44x | 6.68x | 8.27x | 9.51x | 9.48x | 5.01x | 5.01x |
| Debt / Assets | 44.77% | 50.27% | 58.22% | 58% | 54.62% | 59.19% | 65.95% | 41.68% | 35.56% |
| Interest Coverage | 2.95x | 2.70x | 2.41x | 1.85x | 1.72x | 0.85x | 0.47x | 1.07x | - |
| Book Value / Share | 27.83 | 25.14 | 24.25 | 16.27 | 27.63 | 24.91 | 22.09 | 17.64 | 16.7 |
| Revenue Growth | 7.03% | 7.83% | 7.92% | -2.98% | 6.7% | 27.97% | 14.94% | 11.38% | 9.37% |
American Healthcare REIT, Inc. (AHR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 7, 2026·SEC
Mar 18, 2026·SEC
Feb 27, 2026·SEC
American Healthcare REIT, Inc. (AHR) stock FAQ — growth, dividends, profitability & financials explained
American Healthcare REIT, Inc. (AHR) reported $2.20B in revenue for fiscal year 2024. This represents a 124% increase from $980.3M in 2016.
American Healthcare REIT, Inc. (AHR) grew revenue by 11.4% over the past year. This is steady growth.
Yes, American Healthcare REIT, Inc. (AHR) is profitable, generating $27.3M in net income for fiscal year 2024 (-1.8% net margin).
Yes, American Healthcare REIT, Inc. (AHR) pays a dividend with a yield of 1.85%. This makes it attractive for income-focused investors.
American Healthcare REIT, Inc. (AHR) has a return on equity (ROE) of -2.0%. Negative ROE indicates the company is unprofitable.
American Healthcare REIT, Inc. (AHR) generated Funds From Operations (FFO) of $235.8M in the trailing twelve months. FFO is the primary profitability metric for REITs.
American Healthcare REIT, Inc. (AHR) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates